Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.55946 | 72 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.91727 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.41147 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.86001 | 73 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.72369 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.3475 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.94498 | 65 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.44346 | 71 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.38289 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.40057 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.31863 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.3858 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.38959 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.40155 | 71 |